Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
![](https://static.wixstatic.com/media/04ef19_146882ceaa2048e9986d57c56b574415~mv2.jpg/v1/fill/w_120,h_80,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/04ef19_146882ceaa2048e9986d57c56b574415~mv2.jpg)
Updated: May 27, 2023
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.